Introduction
Anterior cervical corpectomy and fusion (ACCF) is a time-tested surgical intervention for patients with cervical spondylosis (CS) that was first described in the 1950s [
1]. Multiple clinical trials have demonstrated favorable outcomes with ACCF. In contrast to the classic intervertebral approach, anterior cervical discectomy and fusion (ACDF), ACCF offers a more extensive operative exposure and a broader decompression range, making it applicable to a wider spectrum of indications, particularly in cases where compression extends to the vertebral level [
1,
2].
Concomitant with the excellent decompressive effect, however, ACCF is reported to induce more intraoperative and postoperative adverse events. Several systematic reviews have consistently indicated a higher overall complication rate in ACCF compared to ACDF [
3,
4]. The extensive corpectomy would inevitably lead to prominent structural disruption and damage, resulting in cerebrospinal fluid (CSF) leakage, haemorrhage and neurological deficit, etc. [
5]. Additionally, the commonly used internal implants in ACCF have also been shown to be associated with adverse events. The anterior plate in ACCF may elevate the likelihood of postoperative dysphagia, adjacent segmental degeneration and instrumental failures [
6]. And the titanium mesh cage (TMC) has been linked to a higher risk of subsidence [
7]. For a subset of patients who present with extensive disc prolapses, localized retrovertebral osteophytes or segmental ossification of posterior longitudinal ligament (OPLL), their decompression requirements may not warrant a traditional corpectomy, while ACCF may expose them to unnecessary risks. To address this concern, we have introduced a novel surgical technique known as anterior
X-shape-corpectomy and fusion (ACXF), which combines one-level ACCF and two-level ACDF, serving as a potential alternative for these patients to achieve adequate decompression with a reduced risk of adverse events.
The aim of this study was to assess the early-stage clinical and radiological outcomes of ACXF for treating two-level CS patients by conducting a retrospective comparison between ACXF and ACCF cohorts.
Discussion
This study evaluated the clinical and radiological outcomes of a novel surgical technique, ACXF, and compared them with those of ACCF in the management of patients with two-level CS. ACXF was originally designed for CS patients with extensive disc prolapses, localized retrovertebral osteophytes or segmental OPLL, who required an intermediate decompression range between that provided by ACCF and ACDF. As ACXF is considered as partial alternative to ACCF, it is important to determine its optimal indications. The current research indicated a gratifying clinical efficacy of ACXF for cases involving compression with a transverse dimension less than 12 mm. All patients exhibited a significant increase in APCD and SCA, rendering sufficient room to release the spinal cord. Correspondingly, their clinical parameters improved as the neurological symptoms were relieved, which was comparable to the outcomes observed after ACCF. However, for patients presenting with extremely lateral disc prolapses, osteophytes or wide-based OPLL, the priority of ACXF may diminish.
ACXF showed superiority in minimalize the surgical trauma. The foundation of ACXF lies in the two-step corpectomy, comprising an initial
V-shaped corpectomy followed by an inverted
V-shaped corpectomy, combinedly forming an
X-shaped profile in the transverse view of the vertebra. The first “
V” groove facilitates the exposure of the operative field, while the second “inverted
V” groove enhances direct anterior decompression. This two-step corpectomy contributes to the preservation of the responsible vertebra, in stark contrast to conventional corpectomy which covers majority of the vertebral body and exposes nearby anatomical structures to potential injuries, increasing the risks of haemorrhage, CSF leakage, infection and neurological deficit [
14,
15]. In ACXF, guided by preoperative and intraoperative imaging, we limited the bone resection within the
X-shaped groove, reducing disruption and damage to surrounding tissues, especially to the nerves and dura mater. In this study, ACXF resulted in relatively less blood loss, significantly shorter drainage durations and less volumes. There were no cases of CSF leakage, haematoma or neurological deficit, and only one case of hoarseness detected among the ACXF cohort, indicating the satisfactory safety of ACXF.
The implants used in ACXF differed from those in conventional ACCF, which typically incorporates anterior plate and TMC. While anterior platerender robust fixation, it could elevate the risk of dysphagia [
16]. In ACXF, two Zero-
P (VA) spacers are employed in lieu of the plate to maintain the intervertebral height and provide internal fixation. Previous articles had compared the both implants and concluded that Zero-
P had better performance than the plate in mitigating dysphagia [
17,
18]. Theoretically, dysphagia following anterior cervical surgery is mainly attributed to the impact on prevertebral structures, which leads to soft tissue swelling and irritation of the oesophagus [
19]. ΔPSTT was adopted to quantify the influence on the prevertebral tissues through the surgery, which had shown a significantly positive correlation with dysphagia [
20]. The data that ACXF exhibited significantly smaller ΔPSTT than ACCF reflected the optimized prevertebral disturbance of the low-profile design of Zero-
P (VA). Consequently, ACXF group experienced a relatively lower dysphagia rate, with only one patient affected and promptly alleviated after appropriate conservative treatment.
Bony fusion and subsidence represent two critical parameters directly linked to surgical outcomes. The conventional use of TMC in ACCF has been praised for satisfactory fusion effect. Nevertheless, the TMC had been noticed with a high rate of subsidence, which could lead to cervical instability, recurrent neurological deteriorations, implant failure and even necessitate revision surgery [
21]. Chen et al. reviewed 300 ACCF cases with TMC and reported that 79.7% of cases were observed with reduction in FSU height during 1 year [
22]. The potential factors contributing to the elevated incidence of subsidence with TMC may include stress concentration resulting from the mismatch between TMC and endplate interfaces, as well as the high stiffness of TMC and excessive endplate grinding during insertion [
23,
24]. In ACXF, we apply in situ bone graft instead of TMC, where we trim and reinsert the
V-shaped autologous bone mass from local vertebrae, thereby preserving structural integrity. Based on our experience, the graft remains spontaneously stable without the need for additional fixation under longitudinal pressure and extrusion from bilateral inclined bony surfaces. The use of in situ bone graft in combination with the Zero-
P (VA) systems enables even interface contact, significantly reducing stress concentration and creating a stable biomechanical environment. Accordingly, our data demonstrated better maintenance of FSU height 1 year after ACXF and confirmed significantly lower subsidence rates of ACXF at all time points compared to contemporary data from ACCF with TMC, as reported by us and previous studies [
12,
25]. Furthermore, the bone graft exposes sufficient bone marrow and allows direct cancellous–cancellous bone contact with the residual vertebra. This facilitates the crawling of new bone without obstruction from cortical bone. Consequently, ACXF group achieved a satisfying fusion rate in the early stages and 1 year after the surgery. Besides, in situ graft approach could substitute iliac bone harvesting and eliminate the risk of donor-site complications.
In other aspects, ACXF group showed comparable efficacy in reconstructing the cervical lordosis and sagittal alignment in comparison with ACCF group. Short-term RASP did not reveal any significant intergroup difference. The above parameters warrant close monitoring during the medium- to long-term follow-up assessments.
It is noteworthy that the adoption of ACXF should be considered with caution for patients with dural adhesions, as the direct separation of the adherent posterior longitudinal ligament and dura sac from an anterior approach carries a significant risk of CSF leakage. Additionally, ACXF is a relatively intricate and technically demanding procedure, especially with decompression after two-step corpectomy, which may pose challenges for grasping. Lastly, during installation of the Zero-P (VA) systems, there exists a risk of screws crossing the graft–vertebra interface and drilling into the graft, which could compromise the holding force of screws and graft vascularization, and further affect the holistic stability of internal fixation and fusion outcome. A modified and dedicated internal fixation system for ACXF technique might be the ultimate solution. Despite these limitations, our study underscored the inspiring outcomes and reduced incidence of adverse events with ACXF. Therefore, it is suggested as a viable surgical alternative for select two-level CS patients, meriting further in-depth investigation.
Some limitations of this study should be emphasized. First, concerning that ACXF was still in its infancy, this study was designed as a non-randomized, single-centre retrospective comparison with a small sample size and short follow-up time, thus some confounders were unavoidable and the level of evidence was low. A multicentre prospective randomized comparison study with a large sample and long-term follow-up should be conducted in the future to corroborate the long-term outcomes and reliability of ACXF. Moreover, further biomechanical and basic research is needed to elucidate the fate of reinserted V-shaped autologous bone mass and its impact on the biomechanical environment of the responsible vertebra and adjacent segments.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.